The World Has a New Global Softgel CDMO: Sofgen CDMO makes its international debut at CPHI Milan
Sofgen CDMO makes its international debut at CPHI Milan, introducing its new global identity and positioning as a trusted softgel CDMO partner. Backed by 50 years of pharmaceutical expertise, Sofgen combines advanced softgel technologies, integrated development and manufacturing capabilities, and a partnership-driven approach to help customers bring products to market with confidence.
Sofgen CDMO®, the integrated pharmaceutical CDMO platform of Sofgen Pharma, will present its new global presence and visual identity at CPHI Milan, marking a significant milestone in the company's evolution and reinforcing its commitment to becoming the trusted partner pharmaceutical companies rely on to develop, manufacture, and commercialize their products.
While the Sofgen CDMO® name is new, it is built on 50 years of trusted pharmaceutical expertise. Bringing together certified manufacturing facilities across the Americas, world-class R&D, regulatory excellence, advanced softgel technologies, and a dedicated global team. Sofgen CDMO® offers an integrated development and manufacturing platform that supports pharma companies at every stage of the product lifecycle. Built on a foundation of quality, flexibility, and long-term partnerships.
Sofgen CDMO® is committed to helping customers bring products to market with confidence.
Finding the right CDMO partner can make the difference between a successful product launch and a missed opportunity. At CPHI Milan, visitors will discover how Sofgen CDMO® combines expertise, specialized softgel capabilities, and a partnership approach helping companies confidently bring their products from development to commercialization.
At the booth, attendees will have the opportunity to explore Sofgen CDMO’s portfolio of differentiated softgel technologies, including:• Unigel™ – an innovative fixed-dose combination softgel platform.• Chewgels™ – flavored chewable softgels designed to enhance the patient experience.• Twistgels™ – twist-off softgel capsules for precise topical and oral applications.• Vaogels™ – specialized vaginal softgel technology engineered for targeted drug delivery.
As part of the Sofgen Pharma group, the booth will also feature Funtrition®, the company’s specialized gummy CDMO, showcasing its advanced nutraceutical gummy capabilities and demonstrating how the organization supports customers across both pharmaceutical and nutraceutical categories through complementary development and manufacturing expertise.
"CPHI Milan represents much more than our participation in the industry's leading event. It is the presentation of Sofgen CDMO's new identity to the global pharmaceutical community, a company built on 50 years of experience and a commitment to earning our customers' trust through quality, flexibility, and true partnership. We believe the best CDMO relationships are built by understanding our customers' goals and working alongside them to bring successful products to market," said Camilo Suarez, Senior Commercial Director.
For existing customers, CPHI Milan is an opportunity to experience the evolution of a trusted manufacturer into a fully integrated global CDMO. For prospective partners, it is an invitation to discover a company whose greatest strength extends beyond its technologies its ability to build lasting partnerships grounded in trust, quality, and flexibility.
Whether you are developing a new pharmaceutical product, expanding an existing portfolio, or searching for a CDMO partner with specialized softgel expertise, our team is ready to help you bring your next project to life.
Schedule your meeting today and discover why the world has a new Global Softgel CDMO.
Visit us at Booth 14B28 or schedule a meeting to reserve a dedicated spot with our team during CPHI Milan.
